European Head and Neck Society recommendations for head and neck cancer survivorship care.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
10 2022
Historique:
received: 23 06 2022
accepted: 22 07 2022
pubmed: 7 8 2022
medline: 30 8 2022
entrez: 6 8 2022
Statut: ppublish

Résumé

Survivors of head and neck cancer can experience long-term consequences of the cancer and subsequent treatments even after the cancer has resolved. Increasingly clinicians are aware of the social, psychological, financial, and emotional impacts of these cancers, in addition to the support required for the physical symptoms. This review provides recommendations on the long-term management and support required for survivors of head and neck cancer in the European healthcare setting.

Identifiants

pubmed: 35932637
pii: S1368-8375(22)00336-0
doi: 10.1016/j.oraloncology.2022.106047
pii:
doi:

Types de publication

Journal Article Practice Guideline Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106047

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Irma Verdonck-de Leeuw (I)

Amsterdam UMC Location Vrije Universiteit Amsterdam, Department Otolaryngology-Head and Neck Surgery, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, the Netherlands; Vrije Universiteit Amsterdam, Department Clinical, Neuro and Developmental Psychology, Van der Boechorststraat 7-9, Amsterdam, the Netherlands; Amsterdam Public Health, Mental Health, Amsterdam, the Netherlands. Electronic address: im.verdonck@amsterdamumc.nl.

Camilla Dawson (C)

Speech and Language Therapist-Dysphagia and Altered Airways University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: Camilla.dawson@nhs.net.

Lisa Licitra (L)

Head and Neck Cancer Medical Oncology Unit and Head & Neck Research Program at the Istituto Nazionale Tumori in Milan, Italy. Electronic address: Lisa.Licitra@istitutotumori.mi.it.

Jesper Grau Eriksen (JG)

Experimental Clinical Oncology, Aarhus University Hospital, Entrance C, Level 1, C108, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark. Electronic address: jesper@oncology.au.dk.

Sefik Hosal (S)

Department of Otolaryngology-Head & Neck Surgery, Atılım University Faculty of Medicine, Ankara, Turkey. Electronic address: sefikhosal@gmail.com.

Susanne Singer (S)

Institute of Medical Biostatistics, Epidemiology, and Informatics, University Hospital of Johannes Gutenberg University Mainz, Germany. Electronic address: singers@uni-mainz.de.

Dominic P Laverty (DP)

Restorative Dentistry, Birmingham Dental Hospital, 5 Mill Pool Way, Birmingham B5 7EG, UK. Electronic address: dominic.laverty1@nhs.net.

Wojciech Golusinski (W)

Department of Head and Neck Surgery Poznan University of Medical Sciences, The Greater Poland Cancer Centre, 15 Garbary St., 61-866 Poznan, Poland. Electronic address: wgolus@ump.edu.pl.

Piotr Machczynski (P)

Department of Head and Neck Surgery Poznan University of Medical Sciences, The Greater Poland Cancer Centre, 15 Garbary St., 61-866 Poznan, Poland. Electronic address: piotr.machczynski@wco.pl.

Ana Varges Gomes (A)

Centro Hospitalar e Universitario do Algarve, Chair of Administration Council, MD Medical Oncologist, Portugal. Electronic address: anafmferreira@yahoo.com.

Charis Girvalaki (C)

European Cancer Patient Coalition, Avenue des Arts 6, 1210 Brussels, Belgium. Electronic address: charis.girvalaki@ecpc.org.

Christian Simon (C)

Chef-de-service, Service d'Oto-rhino-laryngologie et chirurgie cervico-faciale CHUV, UNIL, Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: Christian.Simon@chuv.ch.

C René Leemans (CR)

Department of Otolaryngology - Head and Neck Surgery, Cancer Center Amsterdam, Amsterdam UMC - Vumc, P.O. Box 7057, 1007MB Amsterdam, the Netherlands. Electronic address: cr.leemans@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH